ZIVO 📈 Zivo Bioscience - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98978N2009
ZIVO: Algae, Bioactive Ingredients, Animal Feed, Human Supplements, Medical Food
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan. Web URL: https://www.zivobioscience.com
Additional Sources for ZIVO Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ZIVO Stock Overview
Market Cap in USD | 73m |
Sector | Healthcare |
Industry | Biotechnology |
GiC Sub-Industry | Personal Care Products |
IPO / Inception | 2012-09-24 |
ZIVO Stock Ratings
Growth 5y | 75.0% |
Fundamental | - |
Dividend | - |
Rel. Strength Industry | 6527 |
Analysts | 3/5 |
Fair Price Momentum | 21.73 USD |
Fair Price DCF | - |
ZIVO Dividends
No Dividends PaidZIVO Growth Ratios
Growth Correlation 3m | 32% |
Growth Correlation 12m | 88.6% |
Growth Correlation 5y | 37.3% |
CAGR 5y | 85.95% |
CAGR/Mean DD 5y | 2.05 |
Sharpe Ratio 12m | 1.71 |
Alpha | 339.78 |
Beta | 2.56 |
Volatility | % |
Current Volume | 2.9k |
Average Volume 20d | 1.1k |
What is the price of ZIVO stocks?
As of December 22, 2024, the stock is trading at USD 19.00 with a total of 2,900 shares traded.
Over the past week, the price has changed by -18.41%, over one month by -23.18%, over three months by +17.56% and over the past year by +1084.33%.
As of December 22, 2024, the stock is trading at USD 19.00 with a total of 2,900 shares traded.
Over the past week, the price has changed by -18.41%, over one month by -23.18%, over three months by +17.56% and over the past year by +1084.33%.
Is Zivo Bioscience a good stock to buy?
Yes. Based on ValueRay Analyses, Zivo Bioscience (NASDAQ:ZIVO) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 74.95 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZIVO as of December 2024 is 21.73. This means that ZIVO is currently undervalued and has a potential upside of +14.37% (Margin of Safety).
Yes. Based on ValueRay Analyses, Zivo Bioscience (NASDAQ:ZIVO) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 74.95 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZIVO as of December 2024 is 21.73. This means that ZIVO is currently undervalued and has a potential upside of +14.37% (Margin of Safety).
Is ZIVO a buy, sell or hold?
Zivo Bioscience has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold ZIVO.
Zivo Bioscience has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold ZIVO.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for ZIVO stock price target?
According to ValueRays Forecast Model, ZIVO Zivo Bioscience will be worth about 25.4 in December 2025. The stock is currently trading at 19.00. This means that the stock has a potential upside of +33.47%.
According to ValueRays Forecast Model, ZIVO Zivo Bioscience will be worth about 25.4 in December 2025. The stock is currently trading at 19.00. This means that the stock has a potential upside of +33.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 12 | -36.8% |
Analysts Target Price | 6 | -68.4% |
ValueRay Target Price | 25.4 | 33.5% |